London, United Kingdom
Feebris is positioned at the intersection of AI and health care, aiming to revolutionize community-based diagnosis and monitoring through its mobile platform. The company's mission is to eliminate the disparity in health access by leveraging AI-powered tools to provide quick and efficient healthcare solutions worldwide. Founded in 2019 and headquartered in the United Kingdom, Feebris targets a crucial gap in the healthcare industry by making diagnostics and treatment more accessible, particularly in underserved communities.
The company's recent funding activity includes a Seed Round investment on 01 January 2023, led by KHP Ventures. This demonstrates strong investor confidence in Feebris's vision and the potential market impact of its innovative platform. As the demand for health tech solutions continues to rise, Feebris stands out by combining machine learning with practical healthcare applications, making it an attractive prospect for investors seeking to impact the healthcare sector significantly.
